Join the MICCAI Society Startup Village Pitch Competition - Your Vote Counts!
Sunday 6th July 2025
Dear MICCAI Community,
We are excited to invite you to the MICCAI Society Startup Village pitch competition, taking place virtually on Zoom! This event brings together the most innovative startups in medical imaging and computer-assisted intervention (often based on research papers published at MICCAI!), giving them a platform to showcase their cutting-edge solutions to a global audience.
Nine leading startups were selected to present their pitches, followed by a Q&A session with our expert jury – including representatives from the MICCAI Society, academia, and industry (NVIDIA, AWS & Kitware). As an audience member, you will play a crucial role: your vote will help determine which startups advance to the top, who will earn the opportunity to present their work in person at MICCAI 2025 and receive additional benefits.
Don't miss the unique chance to :
- Discover the latest innovations shaping the future based on topics related to MICCAI
- Be inspired by startups that come from the core of the MICCAI community
- Cast your vote and help select the most promising ventures
Event Details: July 9, 2025 at 8:00 AM (EDT) / 2:00 PM (CEST) / 8:00 PM (CST)
Participating Startups that made it into the pitch competition (in random order):
HistAI
HistAI is a foundational pathology company with one of the largest exclusive pathology datasets, enabling the creation of large-scale AI models and open-source initiatives. Their main product, HistAI CELLDX, is a computational pathology platform powered by advanced AI tools for diagnostics and case management.
HighRAD Ltd
HighRAD provides an FDA-cleared oncology AI imaging platform that automates quantitative analysis for disease progression and treatment efficacy, uniquely supporting multi-organ, multi-modality lesion tracking in oncology patients. Founded by experienced researchers, their platform streamlines the oncology patient journey through advanced imaging analytics.
Scialytics
Scialytics, a spinoff of IHU-Strasbourg, is developing the world’s first AI-powered ecosystem to systematically measure and reduce surgical risk, leveraging minimally invasive surgery data. Their team’s expertise in surgical video analysis underpins products for intraoperative performance assessment and real-time surgical support.
Gray Matter Solutions
Gray Matter Solutions is a digital health company creating AI-powered tools to detect, differentiate, and intervene in early-stage cognitive impairment, including Alzheimer’s and vascular cognitive impairment. Their flagship, ReCOGnAIze, is a clinically validated, gamified cognitive assessment platform bridging machine learning and clinical usability.
SynthesEyes
SynthesEyes, a 2024 medtech startup, develops AI-based multimodal simulation solutions for ophthalmic surgery, integrating computer graphics, vision, and machine learning for high-fidelity surgical scenarios. Their platform supports surgical training and the generation of synthetic data to accelerate AI development in interventional imaging and robotics.
Immunova AI
Immunova AI is a global, youth-led open-source startup redefining precision oncology with an AI pathology platform that predicts personalized immunotherapy response by integrating histopathology, genomics, and clinical data. The company collaborates with leading institutions to make precision oncology more accessible and equitable worldwide.
MIRA Vision Microscopy GmbH
MIRA Vision Microscopy GmbH is a German deep tech B2B SaaS startup solving the AI training data bottleneck in microscopy with patented technology for creating diverse, photo-realistic synthetic datasets. Their cloud-based platform supports biomedical and digital pathology applications, validated for muscle pathology and expanding to other high-impact diseases.
AISI X
AISI X is developing a foundational AI platform for brain disease diagnostics, enabling radiologists and neurologists to work up to 10 times faster by analyzing scans, clinical history, and lab data to detect abnormalities and generate structured reports. Their multimodal system acts as a “digital intern,” reducing cognitive load and streamlining neuroimaging workflows.
MyoIntel
MyoIntel is an early-stage academic team developing a local AI tool for cardiac MRI analysis, enabling fast, clinician-guided detection and segmentation of myocardial scar tissue with a privacy-preserving, offline platform. Their prototype supports efficient, reproducible analysis and is being extended for longitudinal patient tracking and automated reporting.
We look forward to seeing you at the MICCAI Society Startup Village and making your voice heard in this exciting competition! For questions, please contact: startupvillage@miccai2025.org
Best regards,
The MICCAI Society Startup Village Committee